MassDevice1d
Medtronic has a new VP, GM for TAVR, Congenital Heart
Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.
FierceBiotech2d
Jury rules for Axonics in Medtronic’s long-running neuromodulation patent lawsuit
A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...
Neurology Devices Market Review and Forecast 2020-2030 Featuring Abbott Labs, Zimmer Biomet, Medtronic, Stryker, Integra Lifesciences
The "Global Neurology Devices Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Product Type, Treatment Stage, End-Users, Region, By Country: 2020-2030" report has been added to ...
FierceBiotech3d
Awaiting FDA review, Medtronic details study of adaptive neurostimulation in Parkinson’s disease
Medtronic is offering a peek into its ongoing ... study’s results would also help lay the groundwork for adaptive approaches ...
Medtronic teases positive data adaptive deep brain stimulation trial
The company published trial design and preliminary data from the adaptive DBS algorithm for personalized therapy in Parkinson ...
MassDevice4d
Medtronic unveils novel approach to studying adaptive deep brain stim for Parkinson’s
Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...